6533b835fe1ef96bd129efeb

RESEARCH PRODUCT

Incidence of mucositis during therapy with PD1-PDL1 type immune checkpoint inhibitors

Saracino P.Arena C.Mascitti M.Togni L.Mauceri R.Campisi G.Bizzoca M.Lo Muzio L.

subject

immune checkpoint inhibitorsmucositiscancerhttp://hdl.handle.net/10447/455932